• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Why Do Some Mitochondrial Mutations Expand to Overtake All Mitochondria in a Cell?


  • Please log in to reply
6 replies to this topic

#1 reason

  • Guardian Reason
  • 1,101 posts
  • 248
  • Location:US

Posted 08 March 2018 - 11:11 AM


There is a constantly replicating herd of mitochondria in every cell, the evolved descendants of ancient symbiotic bacteria now well integrated into cellular mechanisms. They still bear a small remnant of the original bacterial DNA, however, and this is prone to mutational damage. Some forms of this damage cause mitochondria to both malfunction and become more resilient or more able to replicate than their peers. As a result, the cell is quickly overtaken by broken mitochondria and becomes broken itself, exporting damaging reactive molecules into surrounding tissues, the bloodstream, and the body at large.

This process is one of the root causes of aging, so it is a matter of considerable interest to the research community to understand exactly how it is that these damaged mitochondria can so quickly replicate to fill a cell with their descendants. That said, the beauty of the SENS rejuvenation research approach to the problem is that it really doesn't depend on how the damage occurs or spreads. It aims to place backup copies of mitochondrial genes into the cell nucleus, thus ensuring that there is always a supply of the proteins encoded in mitochondrial DNA. So if mitochondrial DNA does become damaged, then there are no further consequences, and mitochondria will nonetheless continue to function correctly.

An intriguing hallmark of aging in mammals is the appearance of cells carrying significant burdens of mitochondrial DNA (mtDNA) mutants. Unlike the mtDNA mutations which cause inherited diseases, those associated with aging appear to be somatically acquired. Within a given tissue, there is often considerable heterogeneity in the burden of mtDNA mutations, such that affected cells co-exist side by side with healthy cells that carry few, if any, mutations. Furthermore, the frequency of affected cells tends to increase with age and there is evidence that within individual cells, the mitochondrial population is commonly overtaken by a single mutant type, very often a deletion in which a part of the normal mtDNA genome has been lost. The precise mutations tend to differ from one affected cell to another, suggesting that individual mtDNA mutations arise at random. How these mtDNA mutations undergo clonal expansion is a question of longstanding interest.

The possibilities that they multiply either because of a so-called vicious cycle such that defective mitochondria simply generate more reactive oxygen species (ROS), which in turn cause more mutations, or because of random drift, have both been considered but found to be unsatisfactory. Instead, it seems most likely that new mtDNA mutations are acted upon by some form of intracellular selection, causing the expansion of a clone of mutant mitochondria that may come to dominate or entirely exclude the wild type population.

Among the various possibilities to account for a selective advantage favoring mtDNA deletions are that: (i) in a cell where wild type and deleted mtDNA molecules co-exist, there may be a selection advantage for deletion mutants since they have a smaller genome size, which might result in a shorter replication time; (ii) if mitochondria that are compromised by a high burden of mutations have a slower rate of metabolism, they may be less damaged by ROS and so relatively spared from deletion by mitophagy, thereby resulting in survival-based selection through a process that has been termed survival of the slowest; (iii) the selection advantage of mtDNA deletions might be based on features relating to some aspect of the machinery for mtDNA replication, of which several possibilities exist, at least hypothetically.

Possibility (i) has been closely examined but found to be implausible, chiefly because the time required for replication of an mtDNA molecule is only a tiny fraction (less than 1%) of the half-life of mtDNA, which drastically diminishes any scope for a size-based replication advantage to be important. Possibility (ii) has also been found to be unlikely, since not only is it incompatible with mitochondrial dynamics, but it also appears that dysfunctional mitochondria are degraded preferentially rather than more slowly than intact ones By a process of elimination, it appears probable, therefore, that the enigma of clonal expansion of mtDNA deletions requires explanation in terms of the machinery for DNA replication.

Recently, we noticed that when the locations of mtDNA deletions, which had been reported from rats, rhesus monkeys, and humans, were compared, there was a stretch of mtDNA that was overlapped in nearly every instance. Based on this observation and noting that the primer required for DNA replication is provided by processing an mRNA transcript, we suggested a novel mechanism based on this intimate connection of transcription and replication in mitochondria. If a product inhibition mechanism exists that downregulates the transcription rate if sufficient components for the respiration chain exist, then deletion events removing a region of the genome involved in this feedback-loop would confer to such deletion mutants a higher rate of replication priming, leading to a substantial selection advantage. In this article, we report additional data from mice that are strongly consistent with our previous analysis of rats, monkeys, and humans, and we further examine the implications of the hypothesis that a shared sequence, falling within the common overlap of these many individual deletions, might throw light on the underlying mechanism for clonal expansion.

Link: http://dx.doi.org/10.3390/genes9030126


View the full article at FightAging
  • Dangerous, Irresponsible x 1

#2 Turnbuckle

  • Location:USA
  • NO

Posted 08 March 2018 - 01:32 PM

It aims to place backup copies of mitochondrial genes into the cell nucleus, thus ensuring that there is always a supply of the proteins encoded in mitochondrial DNA

 

 

This is a terrible idea, as it would allow mitochondria with defective mtDNA to escape quality control, thus producing a population of poorly functioning mitochondria and accelerating aging.


  • unsure x 1
  • Good Point x 1
  • Agree x 1

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#3 maxwatt

  • Guest, Moderator LeadNavigator
  • 4,949 posts
  • 1,625
  • Location:New York

Posted 08 March 2018 - 03:59 PM

Not necessarily, if the nuclear DNA version of the equivalent mtDNA make up for the deficiencies.  At leas I THINK that is the reasoning motivating this attempt.


  • Ill informed x 1

#4 QuestforLife

  • Location:UK
  • NO

Posted 08 March 2018 - 04:11 PM

But regardless of the mutation, or the mechanism by which the mutation gains a selective advantage - if it reduces membrane potential, it will be picked up by mitophagy (assuming mitophagy is working). So in the presence of functional mitophagy, the only mutations that could gain selective advantage would be those that maintain membrane potential but cause harm in some other way. The only one I can think of off the top of my head might be an increase in membrane potential along with an increase in ROS, but you would think that would be self limiting as ROS itself can damage the membrane and trigger mitophagy. I think a more likely explanation of the dysfunction of mitochondria with age is when mitophagy goes wrong.

 

Turnbuckle - I think the SENS idea is that once integrated into the nuclear DNA mitophagy would no longer be required as the mt genes would be protected by both their distance from the ETC and ROS, and by the normal nuclear DNA repair mechanisms that are absent in mitochondria. I have no idea how you'd get the right proteins back to the mitochondria where they are needed however.


  • Ill informed x 1

#5 Turnbuckle

  • Location:USA
  • NO

Posted 08 March 2018 - 07:49 PM

Not necessarily, if the nuclear DNA version of the equivalent mtDNA make up for the deficiencies.  At leas I THINK that is the reasoning motivating this attempt.

 

 

And that's the problem, this making up of deficiencies. If it were possible to make it all up and get these proteins into the mitochondria, then it might have a chance of working, but short of that mitochondrial function will decay to whatever level can be supported by genes moved into the nucleus. All the mito genes successfully replicated in the nucleus will eventually go bad in the mitochondrial population as quality control can no longer label these mitochondria for removal (because the mitochondria still work using the nuclear proteins, though not very effectively). Some microscopic species have managed to get all the mitochondrial DNA into the nucleus, but those are very few. If you could do that with humans you'd also need to get rid of all mtDNA, as having mtDNA genes that make defective proteins is going to be a massive drag on cellular functioning. And then there's the further problem of eliminating the crosstalk between mitochondria and the nucleus, which has evolved over 1.5 billion years and would cause unknown effects if removed. 

 

The complex crosstalk between mitochondria and the nucleus

 

In addition to these signaling molecules, which monitor cell
metabolic status and thus mitochondrial performance, information
about mitochondrial quality is also transduced to the cell via
specific mitochondria-derived pathways, among which the mitochondrial
unfolding protein response (mtUPR) is gaining much
attention (Mottis et al., 2014). It has also been suggested that
mitochondria-to-nucleus retrograde signaling can be envisioned
as a complementary mechanism to these mitochondrial quality
control systems (Jazwinski, 2013).
 

 

 
This cross talk is also involved with apoptosis and the differentiation of stem cells.

Connecting Mitochondria, Metabolism, and Stem Cell Fate.
 
Given the promising applications of stem cells in regenerative medicine and cell therapy, there is increasing interest in understanding the mechanisms regulating their self-renewal, pluripotency, and plasticity. Recent data support strong and direct involvement of mitochondria and oxidative metabolism in the regulation of stem cell pluripotency [3]. Cells adapt the number and activity of mitochondria in response to environmental and cellular cues through biogenesis, turnover, and fusion and fission processes [4]. Besides playing a fundamental role in energy production through oxidative phosphorylation (OXPHOS), mitochondria play important roles in amino acid, fatty acid, and steroid metabolism, as well as in cell signaling by reactive oxygen species (ROS) production, calcium homeostasis, and apoptosis [4].

 

 

 

Another problem is with platelets. Platelets have mitochondria that must function without nuclear proteins as they have no nucleus. Single cell organisms don't have this problem.

 


Edited by Turnbuckle, 08 March 2018 - 08:00 PM.


#6 HaplogroupW

  • Guest
  • 101 posts
  • 67
  • Location:Flyover country
  • NO

Posted 20 March 2018 - 08:11 PM


 

And that's the problem, this making up of deficiencies. If it were possible to make it all up and get these proteins into the mitochondria, then it might have a chance of working, but short of that mitochondrial function will decay to whatever level can be supported by genes moved into the nucleus. All the mito genes successfully replicated in the nucleus will eventually go bad in the mitochondrial population as quality control can no longer label these mitochondria for removal (because the mitochondria still work using the nuclear proteins, though not very effectively).

 

I see your point. But regarding the article in this particular post, if the authors' thesis is correct, MitoSENS might be helpful in another way. I understand the authors to argue that the basic, pervasive problem is the deletion of a particular portion of the mtDNA loop, not accumulation of point mutations or other such. This deleted portion codes for a protein or proteins (as yet unidentified, although it's around the region that codes for NAD dehydrogenase) that, in healthy mitochondria, provides a "brake" that slows down clonal expansion. Once a loop arises that is missing this, the brakes come off of clonal expansion of this bad mtDNA and it quickly takes over the whole cell (propagating to other mitochondria in fusion events). The mitochondria can function with this deletion as long as enough healthy loops are around to contribute the missing protein(s). But  the healthy loops rapidly become outnumbered and eventually there is metabolic collapse: http://www.mdpi.com/...425/9/3/126/htm

 

From the article:

 

This advantage leads to an accumulation of the mutant mtDNA until the cellular requirement for energy can no longer be satisfied, leading to a collapse caused by ATP exhaustion. The timespan of this accumulation process, from first occurrence of the mutant until the complete takeover turns out to be remarkably short, compared with a human lifespan. With a 10% difference in transcription 3.5 years are required, with a 50% difference this time is reduced to eight months, and if there would be a twofold difference in transcription rates, the accumulation is completed within four months.

 

So if MitoSENS could provide the otherwise-deleted protein that provides the feedback on rate of clonal expansion, then this could keep the "brakes" applied, and prevent the run-away clonal expansion of the deletion-bearing mtDNA loops. Since they no longer have an advantage in rate of expansion, they won't "take over" the cell they way they are currently observed to do.


Edited by HaplogroupW, 20 March 2018 - 08:30 PM.

  • Ill informed x 1

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#7 Turnbuckle

  • Location:USA
  • NO

Posted 20 March 2018 - 09:06 PM

All 37 genes in human mtDNA are essential, so presumably the lack of a single gene would lead to a low membrane potential, which would normally lead to its recycling and thus would be removed before it could take over. If there is a problem with fission or the QC machinery (such as Parkin insufficiency), then that may not happen. One paper referred to "zombie" mitochondria, which are difficult to fission and infect the cell, turning all the mitochondria into zombies. While this was studied in flies, likely it can happen in humans as well--

 

 

When normal mitophagic organelle elimination (Figure 7A) is suppressed by Parkin insufficiency, abnormal undead or zombie mitochondria accumulate and (as zombies will do) contaminate the normal mitochondrial population by fusing with normal organelles (Figure 7B). Mitochondrial fusion that is ordinarily protective, therefore, becomes the mechanism for a general contagion of mitochondrial dysfunction.

https://www.ncbi.nlm...les/PMC4392818/

 

 


Edited by Turnbuckle, 20 March 2018 - 09:07 PM.





0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users